A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk

NCT00572793 · clinicaltrials.gov ↗
COMPLETED
Status
431
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Carl Weiner, MD

Collaborators